Neoplasms: all 9,618 studies
Page 53 of 97. Open to participants first (2,507), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid TumorWithdrawnNCT04797468Phase 1
- Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.Active, not recruitingNCT04795661Phase 2
- A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic MalignancyCompletedNCT04795128Phase 1
- Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors DiagnosisCompletedNCT04793672
- Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)Status unknownNCT04793061
- A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid TumorsWithdrawnNCT04791228Phase 2
- Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With PembrolizumabTerminatedNCT04791215
- Rheumatologic Adverse Events and Cancer ImmunotherapyStatus unknownNCT04791150Not applicable
- Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer PatientsCompletedNCT04790968Not applicable
- Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary LesionsStatus unknownNCT04790747Phase 1/2
- Using Information Technology to Improve Outcomes for Children Living With CancerCompletedNCT04789720Not applicable
- Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer TreatmentCompletedNCT04788758Not applicable
- A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community PopulationCompletedNCT04786704
- A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMMActive, not recruitingNCT04786028Phase 2
- En-Bloc Resection of Bladder TumorsStatus unknownNCT04784507Phase 2
- Prophylactic Cholecystectomy is Not Mandatory in Patients Candidate to the Resection for Small Intestine Neuroendocrine Neoplasms: a Propensity Score-matched and Cost-minimization AnalysisCompletedNCT04780737
- Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study DeviceCompletedNCT04778878
- Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal LymphadenectomyStatus unknownNCT04778826Not applicable
- Multimodality MRI and Liquid Biopsy in GBMWithdrawnNCT04776980Early Phase 1
- Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsCompletedNCT04774952Phase 1
- Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)CompletedNCT04774289
- Balance, Activity and Quality of LifeCompletedNCT04772690Not applicable
- Effect of Dexmedetomidine on Perioperative Internal Environment and Rehabilitation of Patients Undergoing Gastrointestinal Malignant Tumor ResectionCompletedNCT04771637Not applicable
- TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN MutationsTerminatedNCT04770246Phase 1
- The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid TumorsStatus unknownNCT04768868Phase 1
- Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic MalignanciesStatus unknownNCT04767308Early Phase 1
- DISCO: A Patient Intervention to Reduce the Financial Burden of CancerActive, not recruitingNCT04766190Not applicable
- Allogeneic γδ T Cell Therapy for the Treatment of Solid TumorsStatus unknownNCT04765462Phase 1/2
- Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic DiseaseWithdrawnNCT04765423Not applicable
- mHealth Physical Activity Intervention for Young Cancer SurvivorsActive, not recruitingNCT04765241Not applicable
- Mirtazapine in Cancer-related Poly-symptomatologyTerminatedNCT04763135Phase 3
- First in Human Study of UCT-01-097 in Participants With Advanced Solid TumorsTerminatedNCT04761601Phase 1
- Effects of a Multimodal Physical Exercise and Functional Rehabilitation Program on Fatigue, Pain, Functional Capacity and Quality of Life in Cancer Patients With Tumor Asthenia.CompletedNCT04761289Not applicable
- Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast CancerActive, not recruitingNCT04759248Phase 2
- Virtual Reality Experiences for Anxiety and Pain ControlCompletedNCT04759183Not applicable
- Clinical Study of VG161 in Subjects With Advanced Malignant Solid TumorsStatus unknownNCT04758897Phase 1
- Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosisTerminatedNCT04758650Phase 2
- Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up CareCompletedNCT04757545Not applicable
- Surgical Approach for Retrorectal Tumors CohortCompletedNCT04757103
- 89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111WithdrawnNCT04757090Phase 2
- A Study of LP002 for the Treatment of Patients With Malignant Digestive System NeoplasmsStatus unknownNCT04755543Phase 1
- Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer SurvivorsCompletedNCT04754529Not applicable
- Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade III With Non-invasive Physical PlasmaCompletedNCT04753073Not applicable
- 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
- NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 DataActive, not recruitingNCT04750915
- Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.CompletedNCT04749602Phase 2
- Quantification of Abdominal Organ Motion Using MRICompletedNCT04748094
- Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study.CompletedNCT04747600
- Induced-T Cell Like NK Cells for B Cell MalignanciesStatus unknownNCT04747093Phase 1/2
- Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching ProgramCompletedNCT04746859Not applicable
- First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid TumorsTerminatedNCT04746612Phase 1
- Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative NeoplasmCompletedNCT04744974Phase 2
- Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical TreatmentCompletedNCT04744688
- Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic MalignancyStatus unknownNCT04743544
- Viral Specific T Cell Therapy for COVID-19 Related PneumoniaCompletedNCT04742595Early Phase 1
- Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid LeukemiaCompletedNCT04742101Phase 1/2
- IMPACt of an Enhanced Screening Program on the Detection of Non-AIDS NEOplasms in HIV PatientsStatus unknownNCT04735445Not applicable
- An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood CancerActive, not recruitingNCT04733534Phase 2
- EMPOWER 3: Improving Palliative Care Health Literacy and UtilizationCompletedNCT04733469Not applicable
- Metabolic Therapy Program In Conjunction With Standard Treatment For GlioblastomaCompletedNCT04730869Not applicable
- A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid TumorsCompletedNCT04730843Phase 1
- SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIALTerminatedNCT04729725Phase 1
- Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI MalignanciesTerminatedNCT04729205Phase 1
- A Phase 1 Dose Escalation and Expansion Study of AK117CompletedNCT04728334Phase 1
- Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell TransplantationCompletedNCT04727827Not applicable
- 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546CompletedNCT04727138Phase 1
- Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)TerminatedNCT04726332Phase 1
- A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in ChinaCompletedNCT04722055
- Early Clinical Evaluation of 18F-LY3546117 in Tumor ImagingStatus unknownNCT04721756Early Phase 1
- Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE TrialCompletedNCT04721301Phase 1
- Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid TumorsActive, not recruitingNCT04721015Phase 1
- JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid TumorsCompletedNCT04720976Phase 1/2
- Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)Status unknownNCT04720391
- A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid TumorStatus unknownNCT04719065Phase 1
- A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)TerminatedNCT04718675Phase 1/2
- Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise ToleranceCompletedNCT04714840Not applicable
- Effects of COVID-19 Pandemic on the Outcomes of Colorectal CancerStatus unknownNCT04712292
- A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseActive, not recruitingNCT04711252Phase 3
- Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline MutationActive, not recruitingNCT04711109Phase 3
- A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic CancersStatus unknownNCT04710290Phase 2/3
- Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic MalignanciesCompletedNCT04710212
- Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal AnastomosesStatus unknownNCT04709445Not applicable
- Long Term Implications of Rare Brain Tumours'CompletedNCT04708548
- Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant TumorsStatus unknownNCT04708210Phase 1
- LAG3 PET Imaging in Advanced Solid TumorsActive, not recruitingNCT04706715Phase 1/2
- Integrative Neuromuscular Training in Adolescents and Children Treated for CancerActive, not recruitingNCT04706676Not applicable
- Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)Status unknownNCT04704908
- CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant TumorsStatus unknownNCT04702841Early Phase 1
- CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological MalignanciesStatus unknownNCT04700319Early Phase 1
- A Study to Evaluate YH001 in Subjects With Advanced Solid TumorsCompletedNCT04699929Phase 1
- FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid TumorsStatus unknownNCT04699643Phase 1/2
- Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced CancerCompletedNCT04697524Not applicable
- External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT04697446
- CITRuS Stage 1; FeasibilityCompletedNCT04697394
- The Efficacy and Safety of CKD516 Combined With Durvalumab in Patient Refractory Solid TumorsTerminatedNCT04696848Phase 1/2
- Single-Port Versus Multi-Port Robotic Radical ProstatectomyWithdrawnNCT04696263Not applicable
- Development of the Oncology Opportunity Cost Assessment ToolCompletedNCT04694911
- Study of LVGN6051 (CD137 Agonist Antibody) in Advanced or Metastatic MalignancyCompletedNCT04694781Phase 1
- Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.WithdrawnNCT04692389Not applicable
- CD276 CAR-T for Patients With Advanced CD276+ Solid TumorsStatus unknownNCT04691713Not applicable